Feedback

X

Explore

Cancer Biomarkers in Body Fluids

Cancer Biomarkers in Body Fluids

0 Ungluers have Faved this Work
Liquid biopsy shows promise for cancer screening and diagnostics. This reprint collects recent scientific literature on the identification and application of tumor biomarkers in biological fluids to improve the diagnosis of cancer and the identification of optimal therapeutic strategies.

This book is included in DOAB.

Why read this book? Have your say.

You must be logged in to comment.

Rights Information

Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.

Downloads

This work has been downloaded 30 times via unglue.it ebook links.
  1. 30 - pdf (CC BY) at Unglue.it.

Keywords

  • anti-GD2
  • anti-PD-1
  • ASCT
  • Autoantibodies
  • Autoimmunity
  • biomarker
  • biomarkers
  • Bladder cancer
  • blood biomarkers
  • Breast cancer
  • breast cancer biomarkers
  • Cancer
  • cancer biomarkers
  • cancer development
  • cancer pathogenesis
  • cancer progression
  • cancer susceptibility
  • ceramide
  • cerebrospinal fluid
  • cfDNA
  • circulating nucleosomes
  • circulating tumor cells
  • circulating tumor DNA
  • colonoscopy
  • ctDNA
  • Cytokines
  • Diagnosis
  • diagnostic biomarkers
  • Diagnostics
  • dinutuximab
  • disease modelling
  • DNA
  • DNA Methylation
  • E7 oncoprotein
  • early detection
  • Early Diagnosis
  • ELISA
  • epigenetic biomarkers
  • epigenetics
  • exo-oncomiRNAS
  • exosome
  • Exosomes
  • extracellular vesicle
  • extracellular vesicles
  • fecal immunochemical test (FIT)
  • flexible sigmoidoscopy
  • gas chromatography (GC)
  • GM-CSF
  • headspace solid phase microextraction (HS-SPME)
  • hereditary and familial pancreatic cancer
  • HPV antibodies
  • HPV DNA
  • human papillomavirus
  • IL-2
  • immune monitoring
  • Immunotherapy
  • leptomeningeal metastasis
  • linear discriminant analysis (LDA)
  • Lipid
  • lipidomics
  • Liquid Biopsy
  • lung cancer
  • Machine learning
  • mass spectrometry (MS)
  • Mathematics & science
  • Melanoma
  • metabolic pathways
  • metabolic signaling
  • Metabolism
  • metabolomics
  • micro-RNAs
  • microRNA
  • miRNA
  • miRNAs
  • molecular composition
  • molecular pathways
  • mRNA
  • n/a
  • NETs
  • Neuroblastoma
  • next generation sequencing
  • oropharyngeal squamous cell carcinoma
  • outcome
  • ovarian cancer
  • patient stratification
  • personalized medicine
  • phospholipid
  • Physics
  • PKC inhibitor
  • Plasma
  • plasma metabolites
  • plasmalogen
  • plasminogen activator inhibitor-1
  • potentially druggable genes
  • predictive biomarker
  • primary breast cancer
  • principal component analysis (PCA)
  • principal component regression (PCR)
  • prognosis
  • prognostic biomarker
  • prostate cancer
  • Proteins
  • Reference, information & interdisciplinary subjects
  • Research & information: general
  • Response
  • rheumatoid factor
  • RNA sequencing
  • Semen
  • serum
  • small non-coding RNA
  • sncRNA
  • somatic mutation profiling
  • Therapeutics
  • Treatment
  • treatment de-escalation
  • treatment decisions
  • tumor load
  • tumor recurrence
  • TWEAK
  • urine
  • urine liquid biopsy
  • urothelial cancer
  • uveal melanoma
  • volatile organic compounds (VOCs)

Links

DOI: 10.3390/books978-3-0365-6648-1

Editions

edition cover

Share

Copy/paste this into your site: